Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis

Ying Wang1,2, Joshua A Dubland1, Sima Allahverdian1

  • 1From the Departments of Medicine (Y.W., J.A.D., S.A., E.A., B.S., J.E.J., D.D.S., G.A.F.), Centre for Heart Lung Innovation, Providence Healthcare Research Institute, St Paul's Hospital, University of British Columbia, Vancouver, Canada.

Insights

Smooth muscle cells (SMCs) are the main foam cells in mouse models of atherosclerosis, similar to humans. Targeting ATP-binding cassette transporter A1 (ABCA1) may reduce SMC foam cell formation and promote regression.

Area of Science:

  • Cardiovascular Biology
  • Atherosclerosis Research
  • Cell Biology

Background:

  • Smooth muscle cells (SMCs) are abundant in human atherosclerotic lesions.
  • SMCs are implicated in forming atheroma foam cells, but their contribution in mouse models is less clear.
  • Apolipoprotein E-deficient (ApoE-/-) mice are a common model for atherosclerosis research.

Purpose of the Study:

  • To quantify SMC contribution to foam cells in ApoE-/- mice.
  • To assess the utility of ApoE-/- mice for studying SMC foam cell biology.
  • To explore potential therapeutic targets for SMC foam cell formation.

Main Methods:

  • Flow cytometry to characterize foam cells in the aortic arch of ApoE-/- mice.
  • SMC-lineage tracing in ApoE-/- mice fed Western or chow diets.
  • Analysis of foam cell markers and cholesterol transporter ABCA1 expression.

Main Results:

  • Non-leukocyte foam cells, including SMCs, constituted the majority (up to 75%) of foam cells in aged or Western diet-fed ApoE-/- mice.
  • SMCs showed similar foam cell contribution in lineage-traced mice.
  • Non-leukocyte foam cells exhibited lower ABCA1 expression compared to leukocyte-derived foam cells.

Conclusions:

  • SMCs are a major source of foam cells in ApoE-/- mice, mirroring human atherosclerosis.
  • Reduced ABCA1 expression in SMCs is a conserved mechanism for foam cell formation across species.
  • ABCA1 represents a potential therapeutic target for atherosclerosis regression.

Related Concept Videos

Functions of Smooth Muscles01:23

Functions of Smooth Muscles

Smooth muscles are an important type of muscle tissue that plays a vital role in the involuntary movements of internal organs. For example, they help regulate the movement of food through the gut and the flow of blood through the circulatory system.
Function of visceral smooth muscles
Visceral smooth muscle is found in the walls of all hollow organs, except the heart, and is a key player in the involuntary movements that drive the functioning of these internal organs. This tissue is arranged in...
3.4K
Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
7.7K
Structure and Organization of Smooth Muscles01:13

Structure and Organization of Smooth Muscles

Smooth muscle tissue is a type of muscle tissue that can be found lining various vital organs in the human body, including the lungs, blood vessels, digestive tract, and respiratory tract. This type of tissue is responsible for regulating the movements of these organs, playing crucial roles in the functioning of various systems, including the vascular, digestive, respiratory, and urinary systems.
Structure of smooth muscle cell
Smooth muscle cells are spindle-shaped with tapering ends and a...
8.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
371
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.0K
The Role of Actin and Myosin in Non-muscle Cells01:10

The Role of Actin and Myosin in Non-muscle Cells

Actin and myosin or actomyosin filaments also play a significant role in cells other than those involved in muscle contraction (which occurs within the sarcomere of muscle cells). The mechanism of non-muscle cell contractile bundles was first observed in Dictyostelium and Acanthamoeba. In non-muscle cells, two bundles are commonly found: stress fibers and actomyosin adherence belts. These contractile bundles are smaller and less organized than the ones found in muscle cells. They  are held...
4.9K